27763495|t|Auraptene and Other Prenyloxyphenylpropanoids Suppress Microglial Activation and Dopaminergic Neuronal Cell Death in a Lipopolysaccharide-Induced Model of Parkinson's Disease.
27763495|a|In patients with Parkinson's disease (PD), hyperactivated inflammation in the brain, particularly microglial hyperactivation in the substantia nigra (SN), is reported to be one of the triggers for the delayed loss of dopaminergic neurons and sequential motor functional impairments. We previously reported that (1) auraptene (AUR), a natural prenyloxycoumain, suppressed inflammatory responses including the hyperactivation of microglia in the ischemic brain and inflamed brain, thereby inhibiting neuronal cell death; (2) 7-isopentenyloxycoumarin (7-IP), another natural prenyloxycoumain, exerted anti-inflammatory and neuroprotective effects against excitotoxicity; and (3) 4'-geranyloxyferulic acid (GOFA), a natural prenyloxycinnamic acid, also exerted anti-inflammatory effects. In the present study, using an intranigral lipopolysaccharide (LPS)-induced PD-like mouse model, we investigated whether AUR, 7-IP, and GOFA suppress microglial activation and protect against dopaminergic neuronal cell death in the SN. We successfully showed that these prenyloxyphenylpropanoids exhibited these prospective abilities, suggesting the potential of these compounds as neuroprotective agents for patients with PD.
27763495	0	9	Auraptene	Chemical	MESH:C105832
27763495	20	45	Prenyloxyphenylpropanoids	Chemical	-
27763495	81	102	Dopaminergic Neuronal	Disease	MESH:D009410
27763495	108	113	Death	Disease	MESH:D003643
27763495	119	137	Lipopolysaccharide	Chemical	MESH:D008070
27763495	155	174	Parkinson's Disease	Disease	MESH:D010300
27763495	179	187	patients	Species	9606
27763495	193	212	Parkinson's disease	Disease	MESH:D010300
27763495	214	216	PD	Disease	MESH:D010300
27763495	234	246	inflammation	Disease	MESH:D007249
27763495	429	457	motor functional impairments	Disease	MESH:D000068079
27763495	491	500	auraptene	Chemical	MESH:C105832
27763495	502	505	AUR	Chemical	MESH:C105832
27763495	518	534	prenyloxycoumain	Chemical	-
27763495	547	559	inflammatory	Disease	MESH:D007249
27763495	620	634	ischemic brain	Disease	MESH:D020520
27763495	688	693	death	Disease	MESH:D003643
27763495	699	723	7-isopentenyloxycoumarin	Chemical	MESH:C461443
27763495	725	729	7-IP	Chemical	MESH:C461443
27763495	748	764	prenyloxycoumain	Chemical	-
27763495	779	791	inflammatory	Disease	MESH:D007249
27763495	828	842	excitotoxicity	Disease	
27763495	852	877	4'-geranyloxyferulic acid	Chemical	MESH:C552732
27763495	879	883	GOFA	Chemical	MESH:C552732
27763495	896	918	prenyloxycinnamic acid	Chemical	-
27763495	938	950	inflammatory	Disease	MESH:D007249
27763495	1003	1021	lipopolysaccharide	Chemical	MESH:D008070
27763495	1023	1026	LPS	Chemical	MESH:D008070
27763495	1036	1038	PD	Disease	MESH:D010300
27763495	1044	1049	mouse	Species	10090
27763495	1081	1084	AUR	Chemical	MESH:C105832
27763495	1086	1090	7-IP	Chemical	MESH:C461443
27763495	1096	1100	GOFA	Chemical	MESH:C552732
27763495	1152	1173	dopaminergic neuronal	Disease	MESH:D009410
27763495	1179	1184	death	Disease	MESH:D003643
27763495	1230	1255	prenyloxyphenylpropanoids	Chemical	-
27763495	1369	1377	patients	Species	9606
27763495	1383	1385	PD	Disease	MESH:D010300
27763495	Negative_Correlation	MESH:C552732	MESH:D007249
27763495	Negative_Correlation	MESH:C552732	MESH:D003643
27763495	Negative_Correlation	MESH:C105832	MESH:D020520
27763495	Negative_Correlation	MESH:C105832	MESH:D003643
27763495	Positive_Correlation	MESH:D008070	MESH:D010300
27763495	Negative_Correlation	MESH:C461443	MESH:D007249
27763495	Negative_Correlation	MESH:C105832	MESH:D007249
27763495	Negative_Correlation	MESH:C105832	MESH:D009410
27763495	Negative_Correlation	MESH:C461443	MESH:D003643
27763495	Negative_Correlation	MESH:C461443	MESH:D009410

